Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Nov 15, 2019; 11(11): 1065-1080
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.1065
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.1065
Figure 1 Expression of MLH1 and MSH2 in colorectal cancer tissues detected by immunohistochemistry (DAB staining, ×100).
A: MLH1 positivity; B: MLH1 negativity; C: MSH2 positivity; D: MSH2 negativity.
- Citation: Wang SM, Jiang B, Deng Y, Huang SL, Fang MZ, Wang Y. Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer. World J Gastrointest Oncol 2019; 11(11): 1065-1080
- URL: https://www.wjgnet.com/1948-5204/full/v11/i11/1065.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i11.1065